2018
DOI: 10.1007/s00125-018-4720-1
|View full text |Cite
|
Sign up to set email alerts
|

Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study

Abstract: Plasma ceramides demonstrate a biologically complex relationship with metabolic and imaging indicators of dysfunctional adiposity. The role of ceramides in a shared pathway of metabolic dysfunction linking visceral adiposity and insulin resistance requires further investigation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
58
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(62 citation statements)
references
References 40 publications
4
58
0
Order By: Relevance
“…We replicated these results in another cohort, the CoLaus study [2]. Other recent cohort studies yielded similar results with ceramides, but did not report plasma dihydroceramide concentrations [3,4].…”
Section: Introductionsupporting
confidence: 79%
See 1 more Smart Citation
“…We replicated these results in another cohort, the CoLaus study [2]. Other recent cohort studies yielded similar results with ceramides, but did not report plasma dihydroceramide concentrations [3,4].…”
Section: Introductionsupporting
confidence: 79%
“…Among the strengths are the prospective nature of the data. The size of our study may seem limited, however repeated measurements of ceramides were performed, which is not the case in larger cohort studies with only one single measurement [3,4]. We were also able to adjust for confounders such as lifestyle factors.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, in a large multi-ethnic Dallas Heart Study, plasma short-chain saturated ceramides, such as C16:0 and C18:0 were positively linked with insulin resistance, dyslipidemia and visceral adiposity. In contrast, plasma polyunsaturated ceramides (C24:2, C30:10 and C32:11) were inversely associated with these unfavorable phenotypes [130]. These findings suggest that C16:0 and C18:0 ceramides are linked with de-regulated adiposity.…”
Section: Targeting Ceramide Biosynthesis In Adipose Tissuementioning
confidence: 83%
“…With a targetted analysis for the identification of 13 selected species, we found in almonds and pistachios a prevalence of C16:0 ceramide. A recent article (Neeland et al, 2018), reports that circulating shorter-chain saturated fatty acid ceramides (C16:0, C18:0)…”
Section: O-β-d-glucopyranosyl-(2s3r4e8z)-2-[(2r)-2-hydroxyhexadecamentioning
confidence: 99%